Apr 2, 2021 — 3 min read
Join us for our first webinar!
São Paulo: 18:35 - 19:35 PM, Friday, April 9
Sydney: 07:35 - 08:35 AM, Saturday, April 10
Seoul: 06:35 - 07:35 AM, Saturday, April 10
Beijing: 05:35 - 06:35 AM, Saturday, April 10
Bangkok: 04:35 - 05:35 AM, Saturday, April 10
New Delhi: 03:05 - 04:05 AM, Saturday, April 10
Dubai: 01:35 - 02:35 AM, Saturday, April 10
Paris: 23:35 PM, Friday, April 9 - 00:35 AM, Saturday, April 10
Our guest speaker, Dr. Fredrik Strand, MD PhD, from the Karolinska University Hospital in Sweden, will be presenting his studies featuring Lunit INSIGHT MMG, an AI solution for mammography.
He is going to go over his retrospective study published in JAMA Oncology in 2020 where he performed an external evaluation of three artificial intelligence algorithms as independent mammography readers.
Then he will be introducing his prospective clinical trial in a true screening population that had begun recently in March 2021, to further examine to what extent AI can replace or assist radiologists in breast cancer screening.
Here's what you will learn:
The overall performance of Lunit INSIGHT MMG in breast cancer detection, compared to other AI solutions as well as radiologists
The adoption of AI combined with radiologists in clinical settings and routine practice
The aim and design of a prospective clinical trial within full population-based study populations
In the meantime, try online demo to see how accurately and quickly our AI solution can detect breast cancer on mammograms.
Using AI to better manage COVID-19
Lunit to unveil data-driven imaging biomarker at RSNA 2016
Lunit INSIGHT: The First-ever, Real-time Imaging AI Analytics on the Web
Cognitive biases and augmented intelligence in radiology
Uncertainty and Deep Learning
Lunit Returns to RSNA with Real-time Imaging Platform, Featuring Cloud-based A
Lunit Unveils “Lunit INSIGHT,” A New Real-time Imaging AI Platform on the Web at RSNA 2017
Lunit INSIGHT: Q&A with Brandon B. Suh, Chief Medical Officer at Lunit
Lunit Opens “Lunit INSIGHT for Mammography” for Public Access
Lunit Brings its Newest AI Solution for Mammography to RSNA 2018
Lunit Partners with Fujifilm and Salud Digna to Provide Medical AI Solution in Mexico
Lunit announces new members in its advisory board: Dr. Eliot Siegel, Dr. Linda Moy, and Dr. Khan Siddiqui
Lunit to Showcase AI Solution for Breast Cancer at SBI 2019
Lunit Receives Korea MFDS Approval for its AI Solution for Breast Cancer, Lunit INSIGHT MMG
Lunit Gets Korea MFDS Approval for its AI Solution for Chest X-ray, Lunit INSIGHT CXR 2
Lunit at RSNA 2019
Lunit Announces its First CE Mark for AI-Powered Chest X-ray Analysis Software, Lunit INSIGHT CXR
Lunit AI software clinically installed in global sites—to be presented at RSNA 2019
AI-assisted Radiologists Can Detect More Breast Cancer with Reduced False-positive Recall
Lunit INSIGHT MMG, an AI Solution for Breast Cancer Detection, Now CE Certified
Lunit at ECR 2020: Providing Virtual Exhibition and Online Presentations
Emergent Connect Partners with Lunit to Provide Cloud Based AI Solutions
AI Analysis Can Improve Lung Cancer Detection on Chest Radiographs
AI has Added Value in Insurance Underwriting Process, Recent Pilot Project Between Lunit and Cathay Financial Innovation Lab Reveals
RSNA 2020--Lunit Collaborates with Global Giants in Presenting its AI Solution at Virtual Booths of GE Healthcare, FujiFilm, and Sectra
AI Proves Its Value in Assistance for Emergency Cases-- With Higher Accuracy and Timely Reporting Time of Chest Radiographs
Lunit Expands Collaboration with GE Healthcare to Advance AI Adoption across Healthcare Industry
AI Can Offer Fast and Reliable Examination to Triage COVID-19 Patients-- A Multicenter Retrospective Study Reveals
Recent Studies Reveal High Performance of Lunit AI in Breast Cancer Detection
South Korean Medical AI Provider and PACS Leader Enters Indonesian Market, to Help COVID-19 Screening and Diagnosis
What do medical studies say about AI for COVID-19 management?
What do the medical journals say about AI-powered mammography?
Research Using Lunit Demo Website
Lunit Presents AI-powered Pathologic Classification of Immune Phenotype that Predicts Response to Immunotherapy at USCAP 2021
What do the medical journals say about AI-powered chest x-ray interpretation?
From retrospective to prospective trials of AI in breast cancer screening
AACR 2021 - Lunit Presents Abstracts Demonstrating the Potential of its AI Biomarker in Cancer Treatment